Cargando…
The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension
Neurogenic orthostatic hypotension (nOH) is common in patients with neurodegenerative disorders such as Parkinson’s disease, multiple system atrophy, pure autonomic failure, dementia with Lewy bodies, and peripheral neuropathies including amyloid or diabetic neuropathy. Due to the frequency of nOH i...
Autores principales: | Gibbons, Christopher H., Schmidt, Peter, Biaggioni, Italo, Frazier-Mills, Camille, Freeman, Roy, Isaacson, Stuart, Karabin, Beverly, Kuritzky, Louis, Lew, Mark, Low, Phillip, Mehdirad, Ali, Raj, Satish R., Vernino, Steven, Kaufmann, Horacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533816/ https://www.ncbi.nlm.nih.gov/pubmed/28050656 http://dx.doi.org/10.1007/s00415-016-8375-x |
Ejemplares similares
-
Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension
por: Isaacson, Stuart H., et al.
Publicado: (2021) -
Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension
por: Biaggioni, Italo, et al.
Publicado: (2017) -
Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension
por: Gupta, Fiona, et al.
Publicado: (2017) -
Managing neurogenic orthostatic hypotension with droxidopa in a patient with Parkinson disease, atrial fibrillation, and hypertension
por: Mehdirad, Ali, et al.
Publicado: (2017) -
Erratum to: Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension
por: Gupta, Fiona, et al.
Publicado: (2017)